Citigroup
GENE

Citigroup’s Genetic Technologies Ltd. GENE Stock Holding History

Citigroup’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15
Closed – – 7900
2018
Q2 		$0 Hold
15
– – ﹤0.01% 7773
2018
Q1 		$0 Hold
15
– – ﹤0.01% 7709
2017
Q4 		$0 Hold
15
– – ﹤0.01% 7684
2017
Q3 		$0 Hold
15
– – ﹤0.01% 7496
2017
Q2 		$0 Hold
15
– – ﹤0.01% 7519
2017
Q1 		$0 Hold
15
– – ﹤0.01% 7371
2016
Q4 		$0 Hold
15
– – ﹤0.01% 7359
2016
Q3 		$1K Hold
15
– – ﹤0.01% 7002
2016
Q2 		$1K Buy
15
+14
+1,400% +$645 ﹤0.01% 7006
2016
Q1 		$0 Sell
1
-7
-88% -$305 ﹤0.01% 7839
2015
Q4 		$0 Buy
8
+6
+300% +$303 ﹤0.01% 7931
2015
Q3 		$0 Buy
+2
New +$107 ﹤0.01% 7789
2015
Q2 		– Sell
-2
Closed – – 7814
2015
Q1 		$0 Buy
+2
New +$163 ﹤0.01% 7491
2014
Q3 		– Sell
-15
Closed -$2K – 7353
2014
Q2 		$2K Buy
15
+10
+200% +$1.2K ﹤0.01% 6788
2014
Q1 		$1K Buy
5
+2
+67% +$320 ﹤0.01% 6900
2013
Q4 		$0 Sell
3
-1
-25% -$186 ﹤0.01% 7189
2013
Q3 		$1K Buy
+4
New +$952 ﹤0.01% 6704

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
BA
Ballew Advisors Jackson, Mississippi $194M AUM 20.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's GENE Position: Q3 2018 in Review

Citigroup sold out of Genetic Technologies Ltd. (GENE) in Q3 2018, closing a stake of 15 shares.

Citigroup first reported a position in GENE in Q3 2013 and held it in 17 quarters. The position peaked at $2K in Q2 2014. 14 funds tracked by Wall St. Rank hold GENE as of Q3 2018.

  • Citigroup reported no remaining Genetic Technologies Ltd. position as of Q3 2018 after selling out during the quarter.
  • Citigroup sold 15 Genetic Technologies Ltd. shares in Q3 2018.
  • Citigroup first reported a position in Genetic Technologies Ltd. in Q3 2013 and held it in 17 quarters.
  • Citigroup's Genetic Technologies Ltd. position peaked at $2K in Q2 2014.
  • 14 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2018.

Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.